These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7538904)
1. Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. Yasumoto R; Kawanishi H; Tsujino T; Tsujita M; Nishisaka N; Horii A; Kishimoto T Clin Ther; 1995; 17(1):82-7. PubMed ID: 7538904 [TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]. Aoki A; Naito K; Hashimoto O; Yamaguchi M; Hara Y; Baba Y; Wada T; Joko K; Nagao K; Yamakawa G; Suyama K; Nagata K; Matsuyama H; Hirao H; Shimizu Y; Hironaka H; Isoyama R; Takemoto M; Tuchida M; Shiraishi K; Kato M; Kamiryo Y; Harada H; Otsuka T; Mitsui H; Nasu T; Hayashida S; Jojima K; Sacho T; Koshido Y; Harada N Hinyokika Kiyo; 2002 May; 48(5):259-67. PubMed ID: 12094707 [TBL] [Abstract][Full Text] [Related]
3. The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study. Dizeyi N; Mattisson IY; Ramnemark L; Grabe M; Abrahamsson PA Phytother Res; 2019 Sep; 33(9):2457-2464. PubMed ID: 31342610 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of different drugs on the treatment of benign prostate hyperplasia]. Li NC; Wu SL; Jin J; Qiu SP; Kong CZ; Song YS; Ye ZQ; Sun G; Sun YH; Sun YC; Wang XF; Na YQ Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):947-50. PubMed ID: 17961376 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of Cernilton in benign prostatic hypertrophy]. Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). Preuss HG; Marcusen C; Regan J; Klimberg IW; Welebir TA; Jones WA Int Urol Nephrol; 2001; 33(2):217-25. PubMed ID: 12092634 [TBL] [Abstract][Full Text] [Related]
10. Cernilton for benign prostatic hyperplasia. Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Talpur N; Echard B; Bagchi D; Bagchi M; Preuss HG Mol Cell Biochem; 2003 Aug; 250(1-2):21-6. PubMed ID: 12962139 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial. Sengupta G; Hazra A; Kundu A; Ghosh A Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia]. Ju XB; Gu XJ; Zhang ZY; Wei ZQ; Xu ZQ; Miao HD; Zhou WM; Xu RF; Cheng B; Ma JG; Niu TL; Qu P; Xue BX; Zhang W Zhonghua Nan Ke Xue; 2015 Dec; 21(12):1098-101. PubMed ID: 26817302 [TBL] [Abstract][Full Text] [Related]
14. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Buck AC; Cox R; Rees RW; Ebeling L; John A Br J Urol; 1990 Oct; 66(4):398-404. PubMed ID: 1699628 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Dutkiewicz S Int Urol Nephrol; 1996; 28(1):49-53. PubMed ID: 8738619 [TBL] [Abstract][Full Text] [Related]
16. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686 [TBL] [Abstract][Full Text] [Related]
17. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia]. Xu J; Qian WQ; Song JD Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754 [TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of Cernilton on benign prostatic hyperplasia]. Ueda K; Jinno H; Tsujimura S Hinyokika Kiyo; 1985 Jan; 31(1):187-91. PubMed ID: 2581428 [TBL] [Abstract][Full Text] [Related]
19. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. MacDonald R; Ishani A; Rutks I; Wilt TJ BJU Int; 2000 May; 85(7):836-41. PubMed ID: 10792162 [TBL] [Abstract][Full Text] [Related]
20. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia]. Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]